Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||||||||||||
| (単位：百万ドル、1株当たりデータおよびパーセンテージを除く） | 2026 | 2025 | 変更 | 2026 | 2025 | 変更 | ||||||||||||||||
| 収益 | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| 売上総利益率 | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| 営業利益 | $ | 20.8 | $ | 7.9 | NM | $ | 17.6 | $ | 9.8 | NM | ||||||||||||
| 営業利益率 | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| 当期純利益 | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| 希薄化後1株当たり利益 | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| 非GAAP指標* | ||||||||||||||||||||||
| 調整後粗利益率 | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| 調整後EBITDA | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| 希薄化後1株当たり利益 | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % | ||||||||||
*調整後粗利益、調整後EBITDA、および調整後希薄化後1株当たり利益には、非GAAP調整が含まれています。GAAP指標から非GAAP指標への調整表は、本決算発表資料に記載されています。
NM - 意味はない。
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
財務ハイライト
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | ||||||||||||||||
| 2026 | 2025 | 変更 | 2026 | 2025 | 変更 | ||||||||||||
| 用途別売上高 | |||||||||||||||||
| 産業向けソリューション | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| 高度なソリューション | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| 合計 | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % | |||||
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
事業見通しと財務ガイダンス
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
補足財務情報
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
電話会議のお知らせ
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
連絡先
ユージン・フェドトフ
シニア・ディレクター、インベスター・リレーションズ
IPGフォトニクス株式会社
508-597-4713
efedotoff@ipgphotonics.com
IPGフォトニクス株式会社について
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| (単位：千、1株当たりデータを除く） | |||||||||||||
| 売上高 | $ | 287,500 | $ | 250,792 | $ | 831,577 | $ | 729,306 | |||||
| 売上原価 | 170,446 | 151,787 | 502,500 | 446,916 | |||||||||
| 売上総利益 | 117,054 | 99,005 | 329,077 | 282,390 | |||||||||
| 営業費用： | |||||||||||||
| セールス＆マーケティング | 23,934 | 23,771 | 72,286 | 73,753 | |||||||||
| 研究開発 | 31,335 | 30,358 | 95,648 | 88,631 | |||||||||
| 一般管理費 | 37,502 | 35,092 | 110,139 | 102,782 | |||||||||
| 訴訟案件の解決 | - | - | 13,334 | - | |||||||||
| 減損損失 | 231 | - | 17,805 | - | |||||||||
| 事業再編費用 | - | 425 | - | 425 | |||||||||
| 為替差損 | 3,275 | 1,504 | 2,293 | 7,013 | |||||||||
| 営業費用合計 | 96,277 | 91,150 | 311,505 | 272,604 | |||||||||
| 営業利益 | 20,777 | 7,855 | 17,572 | 9,786 | |||||||||
| その他の収入（純額 | |||||||||||||
| 受取利息（純額 | 7,688 | 7,283 | 21,720 | 22,728 | |||||||||
| Other (expense) income, net | (50 | ) | 516 | 2,683 | 2,026 | ||||||||
| その他の収入合計 | 7,638 | 7,799 | 24,403 | 24,754 | |||||||||
| 法人税等調整前利益 | 28,415 | 15,654 | 41,975 | 34,540 | |||||||||
| 法人税等調整額 | 8,142 | 8,191 | 14,876 | 16,714 | |||||||||
| 当期純利益 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | |||||
| 1株当たり当期純利益： | |||||||||||||
| ベーシック | $ | 0.48 | $ | 0.18 | $ | 0.64 | $ | 0.42 | |||||
| 希薄化 | $ | 0.47 | $ | 0.18 | $ | 0.63 | $ | 0.42 | |||||
| 加重平均発行済み普通株式： | |||||||||||||
| ベーシック | 42,531 | 42,199 | 42,416 | 42,427 | |||||||||
| 希薄化 | 42,840 | 42,556 | 42,904 | 42,659 | |||||||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
| 9月30日 | 12月31日 | |||||||
| 2026 | 2025 | |||||||
| (In thousands, except share data) | ||||||||
| 資産 | ||||||||
| 流動資産： | ||||||||
| 現金および現金同等物 | $ | 710,688 | $ | 403,790 | ||||
| 短期投資 | 215,304 | 435,538 | ||||||
| 売掛金（純額 | 191,150 | 181,734 | ||||||
| 棚卸資産 | 337,890 | 313,416 | ||||||
| 未払法人税等 | 33,145 | 43,196 | ||||||
| 前払費用およびその他の流動資産 | 54,460 | 45,766 | ||||||
| 流動資産合計 | 1,542,637 | 1,423,440 | ||||||
| 長期投資 | - | 76,533 | ||||||
| 繰延税金（純額 | 122,235 | 123,889 | ||||||
| のれん代 | 70,281 | 71,735 | ||||||
| 無形資産（純額 | 42,777 | 49,933 | ||||||
| 有形固定資産（純額 | 648,326 | 637,516 | ||||||
| その他の資産 | 45,787 | 41,234 | ||||||
| 総資産 | $ | 2,472,043 | $ | 2,424,280 | ||||
| 負債および資本 | ||||||||
| 流動負債： | ||||||||
| 未払金 | $ | 48,782 | $ | 39,288 | ||||
| 未払費用およびその他の流動負債 | 204,874 | 184,849 | ||||||
| 未払法人税等 | 3,858 | 9,900 | ||||||
| 流動負債合計 | 257,514 | 234,037 | ||||||
| その他の固定負債および繰延税金 | 59,581 | 62,113 | ||||||
| 負債合計 | 317,095 | 296,150 | ||||||
| コミットメントおよび偶発事象 | ||||||||
| 株主資本： | ||||||||
| Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025. |
6 | 6 | ||||||
| Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively. |
(1,558,277 | ) | (1,555,629 | ) | ||||
| 追加払込資本 | 1,097,673 | 1,077,172 | ||||||
| 利益剰余金 | 2,672,063 | 2,644,964 | ||||||
| その他の包括損失累計額 | (56,517 | ) | (38,383 | ) | ||||
| 株主資本合計 | 2,154,948 | 2,128,130 | ||||||
| 負債および株主資本の合計 | $ | 2,472,043 | $ | 2,424,280 | ||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
||||||||
| 9月30日に終了した9ヵ月間 | ||||||||
| 2026 | 2025 | |||||||
| (単位：千） | ||||||||
| 営業活動によるキャッシュ・フロー | ||||||||
| 当期純利益 | $ | 27,099 | $ | 17,826 | ||||
| 当期純利益を営業活動から得た現金(純額)に調整するための調整： | ||||||||
| 減価償却費および償却費 | 47,377 | 46,799 | ||||||
| 減損損失 | 17,805 | - | ||||||
| 在庫引当金、保証引当金、貸倒引当金 | 33,594 | 31,766 | ||||||
| その他 | 25,081 | 21,119 | ||||||
| Changes in assets and liabilities that provided (used) cash: | ||||||||
| 売掛金および買掛金 | 1,535 | 18,787 | ||||||
| 棚卸資産 | (60,189 | ) | (52,005 | ) | ||||
| その他 | (13,771 | ) | (37,757 | ) | ||||
| 営業活動によるキャッシュ・フロー | 78,531 | 46,535 | ||||||
| 投資活動によるキャッシュ・フロー | ||||||||
| 有形固定資産の購入および保証金 | (54,437 | ) | (60,907 | ) | ||||
| 有形固定資産の売却による収入 | 2,204 | 605 | ||||||
| 投資の取得 | (360,732 | ) | (866,402 | ) | ||||
| Purchases of equity investment | (8,000 | ) | - | |||||
| 投資の満期による収入 | 663,124 | 633,731 | ||||||
| 売却目的で保有する資産について、買い手から受け取った預り金 | 2,000 | - | ||||||
| その他 | 111 | 69 | ||||||
| 投資活動によるキャッシュ・フロー | 244,270 | (292,904 | ) | |||||
| 財務活動によるキャッシュ・フロー | ||||||||
| Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans |
(11,053 | ) | (4,316 | ) | ||||
| 自己株式の取得（消費税控除後、取得原価） | (2,648 | ) | (46,603 | ) | ||||
| 財務活動によるキャッシュ・フロー | (13,701 | ) | (50,919 | ) | ||||
| 為替レートの変動が現金、現金同等物および売却目的で保有する現金に及ぼす影響 | (1,727 | ) | 23,274 | |||||
| Net increase (decrease) in cash, cash equivalents and cash held for sale | 307,373 | (274,014 | ) | |||||
| 現金および現金同等物の期首残高 | 403,790 | 620,040 | ||||||
| 現金、現金同等物および売却目的で保有する現金 — 期末残高 | $ | 711,163 | $ | 346,026 | ||||
| キャッシュフロー情報の補足的開示： | ||||||||
| 利息の支払額 | $ | 54 | $ | 136 | ||||
| 所得税の支払額（還付額を差し引いた額） | $ | 9,273 | $ | 44,258 | ||||
| IPGフォトニクス株式会社 非 GAAP 財務指標の補足表（未監査） |
||||||||
非GAAP調整財務情報の使用
We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.
We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.
調整後粗利益率とは、調整後粗利益を総売上高で割ったものを指します。
We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
当社では、EBITDAを、当期純利益に、支払利息（受取利息）、法人税等、減価償却費、および償却費を加算したものと定義しています。
We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.
調整後EPSとは、調整後当期純利益を、希薄化後発行済株式の加重平均数で除したものを指します。
調整後実効税率とは、GAAPに基づく実効税率から、一時的な税務項目および非GAAP調整による純影響額を調整したものを指します。
経営陣は、これらの非GAAP財務指標が、前期比での営業実績を評価するための追加的な手段となると考えています。具体的には、これらの非GAAP財務指標は、経営陣が継続事業の実績や傾向を理解・評価するための追加的な手段となります。これは、継続事業と前期との比較を困難にしたり、継続事業の傾向を不明確にしたり、あるいは経営陣による有用な予測能力を低下させたりするおそれがあると経営陣が判断した、特定の非現金費用やその他の項目を除外することで実現されるものです。
In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.
当社は、将来の見通しに関する非GAAPベースの希薄化後1株当たり調整後利益および調整後EBITDAと、これらに最も直接的に比較可能なGAAPベースの財務指標との間の定量的な調整表を提供しておりません。これは、過度な労力を要することなく、特定の重要な項目の最終的な発生時期または金額を合理的な確実性をもって見積もることができないためです。 これは、希薄化後調整後1株当たり利益および調整後EBITDAに影響を及ぼす様々な項目の時期および／または金額を予測することには、本質的な困難が伴うためです。これには、まだ発生していない項目、当社の支配の及ばない項目、合理的に予測できない項目、および／または意味のある調整や差異が生じない項目が含まれます。同様の理由により、当社は、利用できない情報の予想される重要度について言及することができません。
Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.
| IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED) |
||||||||||||||||
| 売上総利益から調整後売上総利益および調整後売上総利益率への調整 | ||||||||||||||||
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （単位：千、ただしパーセンテージを除く） | ||||||||||||||||
| 売上総利益 | $ | 117,054 | $ | 99,005 | $ | 329,077 | $ | 282,390 | ||||||||
| 売上総利益率 | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||
| 取得関連無形資産の償却 | 720 | 851 | 2,360 | 2,928 | ||||||||||||
| 買収および統合に伴う費用 | - | - | - | 482 | ||||||||||||
| 調整後売上総利益 | $ | 117,774 | $ | 99,856 | $ | 331,437 | $ | 285,800 | ||||||||
| 調整後粗利益率 | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||
Reconciliation of Operating Expenses to Adjusted Operating Expenses
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| （単位：千） | ||||||||||||
| Operating expenses | $ | 96,277 | $ | 91,150 | $ | 311,505 | $ | 272,604 | ||||
| Less: | ||||||||||||
| 取得関連無形資産の償却 | 1,231 | 1,551 | 3,701 | 4,570 | ||||||||
| 買収および統合に伴う費用 | 151 | 246 | 987 | 1,823 | ||||||||
| 減損損失 | 231 | - | 17,805 | - | ||||||||
| 事業再編費用 | 149 | 425 | 500 | 425 | ||||||||
| 訴訟案件の和解および費用 | - | - | 14,435 | - | ||||||||
| 為替差損 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Adjusted operating expenses | $ | 91,240 | $ | 87,424 | $ | 271,784 | $ | 258,773 | ||||
Reconciliation of Operating Income to Adjusted Operating Income
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| （単位：千） | ||||||||||||
| 営業利益 | $ | 20,777 | $ | 7,855 | $ | 17,572 | $ | 9,786 | ||||
| 取得関連無形資産の償却 | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||
| 買収および統合に伴う費用 | 151 | 246 | 987 | 2,305 | ||||||||
| 減損損失 | 231 | - | 17,805 | - | ||||||||
| 事業再編費用 | 149 | 425 | 500 | 425 | ||||||||
| 訴訟案件の和解および費用 | - | - | 14,435 | - | ||||||||
| 為替差損 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| 調整後営業利益 | $ | 26,534 | $ | 12,432 | $ | 59,653 | $ | 27,027 | ||||
当期純利益から調整後EBITDAへの調整
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （単位：千） | ||||||||||||||||
| 当期純利益 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| 受取利息（純額 | (7,688 | ) | (7,283 | ) | (21,720 | ) | (22,728 | ) | ||||||||
| 法人税等調整額 | 8,142 | 8,191 | 14,876 | 16,714 | ||||||||||||
| 減価償却 | 12,986 | 12,392 | 38,447 | 36,120 | ||||||||||||
| 償却 | 2,976 | 3,240 | 8,930 | 10,679 | ||||||||||||
| EBITDA | $ | 36,689 | $ | 24,003 | $ | 67,632 | $ | 58,611 | ||||||||
| 減損損失 | 231 | - | 17,805 | - | ||||||||||||
| 株式報酬 | 11,022 | 10,780 | 31,597 | 32,834 | ||||||||||||
| 事業再編費用 | 149 | 425 | 500 | 425 | ||||||||||||
| 買収および統合に伴う費用 | 151 | 246 | 987 | 2,305 | ||||||||||||
| 訴訟案件の和解および費用 | - | - | 14,435 | - | ||||||||||||
| 為替差損 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| 調整後EBITDA | $ | 51,517 | $ | 36,958 | $ | 135,249 | $ | 101,188 | ||||||||
GAAP純利益と非GAAP純利益の調整、およびGAAP 1株当たり純利益と非GAAP希薄化後1株当たり純利益の調整
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （単位：千、1株当たりデータを除く） | ||||||||||||||||
| 当期純利益 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| 減損損失 | 231 | - | 17,805 | - | ||||||||||||
| 取得関連無形資産の償却 | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||||||
| 事業再編費用 | 149 | 425 | 500 | 425 | ||||||||||||
| 買収および統合に伴う費用 | 151 | 246 | 987 | 2,305 | ||||||||||||
| 訴訟案件の和解および費用 | - | - | 14,435 | - | ||||||||||||
| 為替差損 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| 特定の個別税務項目 | 949 | 3,414 | 84 | 8,303 | ||||||||||||
| 非GAAP調整による税務上の影響 | (711 | ) | (613 | ) | (5,337 | ) | (2,471 | ) | ||||||||
| 調整後純利益 | $ | 26,268 | $ | 14,841 | $ | 63,927 | $ | 40,899 | ||||||||
| 希薄化後1株当たり調整後純利益 | $ | 0.61 | $ | 0.35 | $ | 1.49 | $ | 0.96 | ||||||||
| 希薄化後加重平均発行済株式数 | 42,840 | 42,556 | 42,904 | 42,659 | ||||||||||||
GAAPと非GAAPの実効税率の調整
| 9月30日に終了した3ヵ月間 | 9月30日に終了した9ヵ月間 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| 税率 | 29 | % | 52 | % | 35 | % | 48 | % | ||||||||
| 個別課税項目 | (3 | ) | % | (22 | ) | % | - | % | (24 | ) | % | |||||
| 非GAAP調整による純影響額 | (3 | ) | % | (3 | ) | % | (11 | ) | % | (3 | ) | % | ||||
| 調整後税率 | 23 | % | 27 | % | 24 | % | 21 | % | ||||||||
